Tiny Biotech Wins Permanent Injunction Against Eli Lilly

Law360, New York (April 26, 2006, 12:00 AM EDT) -- A small biotech company has won a permanent injunction against Eli Lilly & Co. in a two-year battle waged over a patent application for technology used to convert injectable-only drugs into ones that can be taken orally, marking another triumph in its long-running fight against the pharmaceutical giant.

A federal judge this week granted Emisphere Technologies Inc.’s oral GPL patent application and ordered Lilly to assign to Emisphere the patent application filed by Lilly in February 2002.

Lilly had argued that Emisphere’s request for the injunction...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.